NuGen Medical Devices Inc.

TSXV:NGMD Stock Report

Market Cap: CA$16.3m

NuGen Medical Devices Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Lin Liang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2yrs
Board average tenure2yrs

Recent management updates

Recent updates

CEO

Lin Liang

no data

Tenure

Mr. Lin Liang is Executive Chairman of NuGen Medical Devices Inc. from November 2024 and serves as its Chief Executive Officer since January 2025 and is its Director from September 2024. He is the founder...

Leadership Team

NamePositionTenureCompensationOwnership
Veronique Laberge
CFO & Secretary1.8yrsCA$183.00k0.34%
CA$ 56.3k
Nicky Canton
Executive VP & COOno dataCA$211.97k0.046%
CA$ 7.5k
Karen Dunlap
Chief Customer Officer & Director2.1yrsCA$142.80k0.069%
CA$ 11.2k
Lin Liang
CEO & Executive Chairmanno datano datano data
Elisha Dillon
Head of Global Sales & Strategic Partnerships3.2yrsno datano data

2.0yrs

Average Tenure

41yo

Average Age

Experienced Management: NGMD's management team is not considered experienced ( 2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Karen Dunlap
Chief Customer Officer & Director3.3yrsCA$142.80k0.069%
CA$ 11.2k
Lin Liang
CEO & Executive Chairmanless than a yearno datano data
Erik Emerson
Member of Advisory Board2.3yrsno datano data
Arvind Rai
Directorless than a yearno datano data
John Leombruno
Independent Director3.3yrsno data2.43%
CA$ 396.4k
Greg Gironda
Member of Advisory Board2.3yrsno datano data
Philip Cortese
Independent Director2yrsno datano data
Louise Cresswell
Directorless than a yearno datano data
Kwun Liu
Directorless than a yearno datano data

2.0yrs

Average Tenure

54yo

Average Age

Experienced Board: NGMD's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 09:42
End of Day Share Price 2025/01/21 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NuGen Medical Devices Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution